[Form 4] QuantumScape Corp Insider Trading Activity
Rhea-AI Filing Summary
Jeffrey B. Straubel, a director of QuantumScape Corporation (QS), exercised stock options and sold shares under a Rule 10b5-1 trading plan. On 09/12/2025 he exercised options to purchase 130,067 shares at an exercise price of $2.377 per share, creating 130,067 additional Class A shares owned via option exercise. The same day he sold 157,180 shares at a weighted-average price of $9.1997 per share (sales occurred at prices ranging $8.725 to $9.955). After these transactions he beneficially owned 348,146 shares, which includes 48,192 RSUs subject to vesting. The transactions were reported on Form 4 and executed pursuant to a 10b5-1 plan adopted June 13, 2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director exercised low-cost options and sold a portion of shares under a 10b5-1 plan; holdings declined materially.
The reporting shows a routine insider option exercise and contemporaneous sale executed under a pre-established Rule 10b5-1 plan. The option exercise at $2.377 created 130,067 shares while the sales of 157,180 shares at a weighted-average $9.1997 reduced total beneficial ownership to 348,146 shares. Sales occurred across a price range of $8.725 to $9.955 and included RSUs totaling 48,192 that remain subject to vesting. From an investor-impact perspective, this is a material insider disposition in absolute terms but consistent with planned trading rather than ad hoc liquidation.
TL;DR: Use of a documented 10b5-1 plan provides procedural compliance; transaction size is notable for governance disclosure.
The Form 4 discloses that the director adopted a trading plan on June 13, 2025, and that the reported exercises and sales were effected pursuant to that plan. Reporting includes transparent disclosure of exercise price, sale weighted-average price, and the range of prices for sold shares. The filing also clarifies that 48,192 shares are RSUs subject to vesting, which affects near-term beneficial ownership. Overall the filing meets Section 16 transparency requirements and shows adherence to a pre-established trading policy.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 130,067 | $0.00 | -- |
| Exercise | Class A Common Stock | 130,067 | $2.377 | $309K |
| Sale | Class A Common Stock | 157,180 | $9.1997 | $1.45M |
Footnotes (1)
- The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.725 to $9.955, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Includes 48,192 shares represented by Restricted Stock Units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Class A Common Stock of the Issuer per the applicable vesting schedule, subject to the Reporting Person's continued service as of each vesting date.